We are thrilled to announce that the US @FDA has granted De Novo marketing authorization for our AI-powered SCANLY Home OCT, the first-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patients.
https://t.co/Rz0F1WDNYn
#homeOCT#AI
Great ForeseeHome catch by Henry Bausback, MD and The Eye Associates team. Referred in Apr 2025, this highly consistent tester alerted in Feb 2026. The alert led to wet AMD diagnosis and prompt treatment while vision was still 20/25.
#AMD#retina#eyesoninnovation#digitalhealth
Home OCT is more than a device. It is a connected care model supporting wet AMD monitoring between visits. In this Retina Synthesis discussion, Prof. Anat Loewenstein shares why validated AI, patient support, and physician oversight matter.
Listen here: https://t.co/Z3NtXRJOea
“The home eye exam” is part of the eye care conversation. This article highlights both ForeseeHome and SCANLY Home OCT as examples of how home monitoring can support physicians with information between regularly scheduled office visits.
Read more: https://t.co/JeaPbkRtRg
Eight years of consistent ForeseeHome testing. One important alert. A 20/20 wet AMD diagnosis.
Congratulations to Rahul Komati, MD and the Georgia Retina team on an outstanding catch that highlights the value of long-term monitoring.
#maculardegeneration#retina#digitalhealth
A great catch by Scott Prickett and @TheEyeAssociate team with #ForeseeHome.
Referred in Nov. 2025 with 20/30 vision, patient alerted in early Feb. 2026. Wet #AMD conversion was diagnosed while vision remained 20/30. Proud to support monitoring patients between visits.
Tennessee Retina participated in Accessibility Day at the Tennessee State Library & Archives, where #ForeseeHome was included among the tech highlighted at their table.
Thanks to their team for helping bring important #eyehealth conversations and resources into the community.
A great ForeseeHome catch by Dr. Ladd and the Virginia Eye Institute team. After 5.5 years of testing, this patient’s wet AMD conversion was diagnosed at 20/20 vision. A good reminder of the value of consistent monitoring between visits. #AMD#eyesoninnovation#digitalhealth
Congrats to Atul Sharma and the Georgia Retina team on a #ForeseeHome catch! Already wet in one eye, patient referred in Nov 2022 to monitor the fellow eye and remained a consistent tester. In Jan 2026, wet #AMD conversion was diagnosed after ForeseeHome alert at 20/20 vision.
Takeaway from @OptometryTimes interview w/ Carolyn Majcher, OD: early wet #AMD detection is best when in-office #OCT and home monitoring work together. OCT remains standard of care in office, and #ForeseeHome adds another layer of monitoring btw visits. https://t.co/3PE5d0qAUP
A meaningful ForeseeHome catch for Majda Hadziahmetovic and the Duke Eye Center team.
Patient referred in early Jan 2026 with 20/20 VA, and wet #AMD conversion diagnosed March 2026 while vision was still 20/20. An important example of monitoring between visits.
Congratulations to Ryan Deasey and the Virginia Eye Institute team on a ForeseeHome catch. Referred in Oct 2025 with 20/60 vision, patient alerted in less than 2 months, prompting exam and wet #AMD diagnosis at 20/60-1. A meaningful example of monitoring patients between visits.
Optometrists do so much more than help patients see clearly. They are often the primary eye care doctors patients know and trust most—detecting, managing, and monitoring medical eye conditions that can impact long-term vision. #WorldOptometryDay
A noteworthy ForeseeHome catch by Kathryn Hecker and Hecker Eye Care Associates.
After 5+ years of testing, wet #AMD conversion was identified at 20/50-3. Same eye had a prior non-exudative alert—signals that may indicate higher risk and warrant closer monitoring.
Advanced at-home monitoring is an important part of the #AMD conversation.
@AcademyEyeSmart highlights role of AMD home monitoring. SCANLY Home OCT and ForeseeHome enable remote disease monitoring between office visits.
https://t.co/jxqsNWCzah
#Retina#HomeMonitoring#HomeOCT
Congrats to Dr. Katia Taba and the Retina Group of Florida team on a ForeseeHome catch case.
Patient referred with 20/30 vision generated alert a month later, leading to a wet #AMD diagnosis at 20/50. Without home monitoring, the next exam may have been months away.
Live from the #MaculaSociety 2026 meeting in San Diego. Prof. Anat Loewenstein shared data on longitudinal #HomeOCT trajectories in nAMD using AI-based NOA.
AI-based analysis differentiated stable vs. changing patterns, with personalized thresholds improving sensitivity.
After over 5 years of monitoring with the ForeseeHome AMD Monitoring Program, this patient experienced a timely detection of wet #AMD in the left eye thanks to Dr. Melissa Summerfield and the North Iowa Eye Clinic team.
Early detection makes the difference in AMD management!
After just 9 months of consistent monitoring, this patient’s progression to wet AMD was detected early—while vision was still 20/25 – thanks to Joseph Anderson, OD, and team.
ForeseeHome serves as a vital safety net, helping detect early changes between office visits.
Dr. Puliafito & Dr. Leng discuss research evaluating AI analysis of daily Home OCT imaging in neovascular AMD. The study highlights the potential value of personalized change thresholds when assessing disease activity over time.
Watch/listen now: https://t.co/qhzC0WZ7vB